Home > Compliance Monitoring > DetectiMed® Panel for Prescription Drug Testing

Your partner in prescription drug testing and therapy management

When it comes to prescription drug testing and management, better information leads to better outcomes. The DetectiMed® Panel, part of AIT’s prescription drug testing services, is designed to help healthcare practitioners make objective, informed decisions regarding patient care. Whether you are performing a baseline evaluation, monitoring compliance, or adjusting a treatment plan, DetectiMed is a powerful tool for any practice.

Why should you use AIT’s DetectiMed Panel to monitor patient compliance? 

• Optimize therapeutic treatment plans for your patients
• Maximize patient safety by minimizing risks associated with specific drug combinations
• Confirm a patient’s self-report regarding current medications
• Include as part of a baseline evaluation for new patients
• Minimize potential for abuse, misuse, and diversion

How does DetectiMed work? 

DetectiMed uses an immunoassay screen to determine both the presence of prescription drugs and illegal narcotics featured in a dozen general drug classes, including:

• Alcohol
• Amphetamines
• Barbiturates
• Benzodiazepines
• Cannabinoids
• Cocaine
• Fentanyl
• Methadone
• Opiates
• Tramadol
• Propoxyphene

AIT validates each specimen by testing for adulterants and detecting metabolites to verify ingestion, and a confirmation test is performed on all positive screens, providing unambiguous identification and quantitation of all substances present in the specimen. Clients can expect to receive results in as little as 48 hours, including quantitative confirmation on positive samples.

View our panels for urine and blood here. 

To view a sample toxicology report featuring prescription drug testing and narcotics testing results from AIT, click here. 

Benefits of DetectiMed 

Comprehensive 

• More than 40 substances detected, including metabolites 
• Sophisticated screening and confirmation methods

Sensitivity 

• Some of the lowest cut-off levels available
• Significantly decreased false negatives

Specificity 

• Confirmation technology provides unique “chemical fingerprint”
• No false positives

Specimen Validity 

• Adulteration testing included
• Detection of metabolites to verify ingestion

Quality Standards 

• Stringent chain of custody
• CAP, CLIA, ISO, and ABFT certified 
• Results available via secure client portal 

In-House Billing Support 

• Vast network of insurance providers
• Flexible payment plans for patients without insurance
• Respect for the patient is key

Long-Lasting Partnership 

• Free toxicology consulting
• Responsive client services department
• Well-educated account executives
• Non-accredited education program 

For more information about AIT’s DetectiMed Panel and our prescription drug testing services, contact our Client Services Department.